Background: Lynch syndrome is an autosomal dominant cancer predisposition syndrome classically caused by germline mutations of the mismatch repair genes MLH1, MSH2, MSH6 and PMS2. Epimutation (also called germline hypermethylation) of the MLH1 gene promoter explains rare Lynch syndrome cases. To date, there is no recommendation regarding the techniques to be used to detect this epimutation, nor any clinical criteria for when it should be investigated.
View Article and Find Full Text PDFClin Cancer Res
April 2025
Purpose: The detection of ctDNA, which allows noninvasive tumor molecular profiling and disease follow-up, promises optimal and individualized management of patients with cancer. However, detecting small fractions of tumor DNA released when the tumor burden is reduced remains a challenge.
Experimental Design: We implemented a new, highly sensitive strategy to detect bp resolution methylation patterns from plasma DNA and assessed the potential of hypomethylation of long interspersed nuclear element-1 retrotransposons as a noninvasive multicancer detection biomarker.